Concise Reviews: Stem Cells and Kidney Regeneration: An Update

Abstract Significant progress has been made to advance stem cell products as potential therapies for kidney diseases: various kinds of stem cells can restore renal function in preclinical models of acute and chronic kidney injury. Nonetheless this literature contains contradictory results, and for t...

Full description

Bibliographic Details
Main Authors: Julia Marcheque, Benedetta Bussolati, Marie Csete, Laura Perin
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Stem Cells Translational Medicine
Subjects:
Online Access:https://doi.org/10.1002/sctm.18-0115
id doaj-dd3d4e2d938c45bead2127a84abdffec
record_format Article
spelling doaj-dd3d4e2d938c45bead2127a84abdffec2020-11-24T21:40:46ZengWileyStem Cells Translational Medicine2157-65642157-65802019-01-0181829210.1002/sctm.18-0115Concise Reviews: Stem Cells and Kidney Regeneration: An UpdateJulia Marcheque0Benedetta Bussolati1Marie Csete2Laura Perin3GOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Children's Hospital Los Angeles, Division of Urology Saban Research Institute, University of Southern California Los Angeles CaliforniaDepartment of Molecular Biotechnology and Health Sciences University of Torino ItalyMedical Engineering California Institute of Technology Los Angeles CaliforniaGOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Children's Hospital Los Angeles, Division of Urology Saban Research Institute, University of Southern California Los Angeles CaliforniaAbstract Significant progress has been made to advance stem cell products as potential therapies for kidney diseases: various kinds of stem cells can restore renal function in preclinical models of acute and chronic kidney injury. Nonetheless this literature contains contradictory results, and for this reason, we focus this review on reasons for apparent discrepancies in the literature, because they contribute to difficulty in translating renal regenerative therapies. Differences in methodologies used to derive and culture stem cells, even those from the same source, in addition to the lack of standardized renal disease animal models (both acute and chronic), are important considerations underlying contradictory results in the literature. We propose that harmonized rigorous protocols for characterization, handling, and delivery of stem cells in vivo could significantly advance the field, and present details of some suggested approaches to foster translation in the field of renal regeneration. Our goal is to encourage coordination of methodologies (standardization) and long‐lasting collaborations to improve protocols and models to lead to reproducible, interpretable, high‐quality preclinical data. This approach will certainly increase our chance to 1 day offer stem cell therapeutic options for patients with all‐too‐common renal diseases. Stem Cells Translational Medicine 2019;8:82–92https://doi.org/10.1002/sctm.18-0115Adult stem cellsKidneyMesenchymal stem cellsRenal
collection DOAJ
language English
format Article
sources DOAJ
author Julia Marcheque
Benedetta Bussolati
Marie Csete
Laura Perin
spellingShingle Julia Marcheque
Benedetta Bussolati
Marie Csete
Laura Perin
Concise Reviews: Stem Cells and Kidney Regeneration: An Update
Stem Cells Translational Medicine
Adult stem cells
Kidney
Mesenchymal stem cells
Renal
author_facet Julia Marcheque
Benedetta Bussolati
Marie Csete
Laura Perin
author_sort Julia Marcheque
title Concise Reviews: Stem Cells and Kidney Regeneration: An Update
title_short Concise Reviews: Stem Cells and Kidney Regeneration: An Update
title_full Concise Reviews: Stem Cells and Kidney Regeneration: An Update
title_fullStr Concise Reviews: Stem Cells and Kidney Regeneration: An Update
title_full_unstemmed Concise Reviews: Stem Cells and Kidney Regeneration: An Update
title_sort concise reviews: stem cells and kidney regeneration: an update
publisher Wiley
series Stem Cells Translational Medicine
issn 2157-6564
2157-6580
publishDate 2019-01-01
description Abstract Significant progress has been made to advance stem cell products as potential therapies for kidney diseases: various kinds of stem cells can restore renal function in preclinical models of acute and chronic kidney injury. Nonetheless this literature contains contradictory results, and for this reason, we focus this review on reasons for apparent discrepancies in the literature, because they contribute to difficulty in translating renal regenerative therapies. Differences in methodologies used to derive and culture stem cells, even those from the same source, in addition to the lack of standardized renal disease animal models (both acute and chronic), are important considerations underlying contradictory results in the literature. We propose that harmonized rigorous protocols for characterization, handling, and delivery of stem cells in vivo could significantly advance the field, and present details of some suggested approaches to foster translation in the field of renal regeneration. Our goal is to encourage coordination of methodologies (standardization) and long‐lasting collaborations to improve protocols and models to lead to reproducible, interpretable, high‐quality preclinical data. This approach will certainly increase our chance to 1 day offer stem cell therapeutic options for patients with all‐too‐common renal diseases. Stem Cells Translational Medicine 2019;8:82–92
topic Adult stem cells
Kidney
Mesenchymal stem cells
Renal
url https://doi.org/10.1002/sctm.18-0115
work_keys_str_mv AT juliamarcheque concisereviewsstemcellsandkidneyregenerationanupdate
AT benedettabussolati concisereviewsstemcellsandkidneyregenerationanupdate
AT mariecsete concisereviewsstemcellsandkidneyregenerationanupdate
AT lauraperin concisereviewsstemcellsandkidneyregenerationanupdate
_version_ 1725924620784107520